Dr. Gregory Fahy
Co-founder, Intervene Immune
Dr. Gregory Fahy is Co-founder, Intervene Immune at Intervene Immune Inc.. Areas of expertise include Thymus regeneration, Immune system aging, Longevity biotechnology, Epigenetic aging.
Biography
Dr. Gregory Fahy is a co-founder of Intervene Immune, a longevity biotechnology company researching age-related immune decline and thymus regeneration. His work focuses on immunosenescence, immune function, and biomarkers of biological aging. Intervene Immune's preliminary TRIIM study, published in Aging Cell in 2019, reported evidence of thymus regeneration and changes in epigenetic aging biomarkers. The company is advancing this research through TRIIM-X, investigating personalized treatment protocols and immune profiling. These early findings remain investigational. Larger controlled clinical trials are needed to establish long-term safety, clinical effectiveness, and any effect on human healthspan or lifespan.
